Accuro XV Ultrasound Imaging System for BoneEnhance and Fracture Detection Algorithms

Part of paid clinical trials in San Francisco, California.

Sponsor
Rivanna Medical, Inc.
Study ID
NCT07853768
Status
Recruiting

Conditions

  • Ankle Injury
  • Fracture Arm
  • Fracture Leg
  • Wrist Injury

Eligibility Criteria

Sex
ALL
Age
5 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Accuro XV Ultrasound Imaging System — DEVICE
    The Accuro XV Ultrasound Imaging System is a cart-based ultrasound imaging device designed to acquire volumetric images of bone and soft tissue anatomy of the distal extremities. In this study, participants will undergo additional Accuro XV imaging following standard-of-care imaging for a distal extremity injury. The imaging procedure includes acquisition of multiple views of the injured anatomy using ultrasound technology and advanced image-processing methods to generate three-dimensional representations of bone and soft tissue structures. Images collected during the study will be used to evaluate device feasibility, safety, image quality, and to support the development and testing of future algorithms. Accuro XV imaging results will not be used for clinical decision-making.

Study Details

The Accuro XV is a cart-based, bedside ultrasound instrument that incorporates new signal processing-based technologies for enhanced bone and soft-tissue imaging. Patients presenting to the Study Setting (e.g., Emergency Departments, urgent care centers, orthopedic clinics, radiology departments, and other clinical environments with access to standard-of-care (SOC) imaging with a suspected distal extremity injury (wrist, forearm, ankle, or lower leg) who have undergone SOC imaging during their clinical evaluation, will be enrolled for additional extremity imaging with the Accuro XV. In this feasibility study, investigators will assess the safety of Accuro XV by review of any adverse events (AEs) and by comparing the comfort level of patients during Accuro XV image capture and standard-of-care imaging. Investigators will retrospectively assess image quality by reviewing all images captured to ensure the image is clear of artifact and other visual imperfections. The de-identified imaging data will then be used for algorithm development and testing. This data will help to verify plans for future study protocols and help to ensure the device is optimized for its clinical use prior to further clinical studies. The results will also be used as an input to RIVANNA's usability and human factors engineering process per IEC 60601-1-6 as recognized by FDA. The Accuro XV is investigational in this study and is not intended to guide clinical decision-making.

Key Dates

First listed
Oct 2, 2026
Start date
Jan 29, 2024
Status verified
Oct 2026
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
25,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Accuro XV Imaging
    Participants with a distal extremity injury who have undergone standard-of-care imaging will receive additional imaging with the Accuro XV ultrasound imaging system. Accuro XV imaging will be performed after completion of standard-of-care clinical imaging and will not be used for clinical decision-making or patient management. Imaging data collected during the study will be used to evaluate device feasibility, safety, image quality, and to support the development and testing of future algorithms.

Primary Outcome Measure

Accuro XV Image Quality Assessment [ Time Frame: From Accuro XV image acquisition through completion of retrospective image-quality assessment, up to 48 months. ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
The University of California San FranciscoSan FranciscoCalifornia94143
Elizabeth Butrick
4156016399
Aaron Kornblith, MD (PRINCIPAL_INVESTIGATOR)
The University of Colorado DenverDenverColorado80204
Carolynn Lyle
3036025235
Matthew Riscinti, MD (PRINCIPAL_INVESTIGATOR)
Yale UniversityNew HavenConnecticut06510
Ryan Denkewicz, MD
4013396076
Cristiana Baloescu, MD (PRINCIPAL_INVESTIGATOR)
Rush University Medical CenterChicagoIllinois60612
Michael Gottlieb, MD
(312) 952-6615
Michael Gottlieb, MD (PRINCIPAL_INVESTIGATOR)
Thomas Jefferson University HospitalPhiladelphiaPennsylvania19107
Nicole Renzi
215-955-2471
Jason Fields, MD (PRINCIPAL_INVESTIGATOR)
The University of Texas SouthwesternDallasTexas75390
Riley Martin
2146482147
Philip Jarrett, MD (PRINCIPAL_INVESTIGATOR)
Texas Tech University Health Sciences CenterEl PasoTexas79905
Diluma Kariyawasam
9152154649
Kara Samsel, MD (PRINCIPAL_INVESTIGATOR)
The University of UtahSalt Lake CityUtah84112
Marina Griffith
8015298668
Christopher Kelly, MD (PRINCIPAL_INVESTIGATOR)
The University of VirginiaCharlottesvilleVirginia22904
Ashley Simpson
4349242897
Christopher Thom, MD (PRINCIPAL_INVESTIGATOR)
Virginia Commonwealth UniversityRichmondVirginia23298
Samuel Chun
8049555067
Jordan Tozer (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

Related Studies